Research
These microcarriers may offer an entirely different approach to treating solid human tumors of numerous pathologic subtypes by delivering their encapsulated drug cargo to a tumor and protecting against collateral tissue damage.
Just one month after major research findings showed dangerous PFAS present in more than one-third of fast food packaging tested, UAB and Notre Dame created a new technique to track PFASs in the body.

Unusual case of teen patient diagnosed with colorectal cancer receives innovative first-in-human clinical trial at UAB, reflecting a unique story of cancer and hope.

UAB’s School of Dentistry has ranked first in NIDCR funding since 2012.
UAB doctoral student Ajaya Neupane awarded highly competitive $50,000 fellowship to continue research using neuroimaging devices to examine internet users’ susceptibility to cyberattacks.
New data from the REGARDS study show that blacks with the sickle cell trait are more likely to develop kidney failure requiring dialysis.

New research from UAB sheds light on the connection between Parkinson’s disease and the trillions of bacteria in our guts. 

A 90-ton machine called a cyclotron will accelerate protons to very high speeds to impact human tumors.
The function and structure of protein GARP2 in rod cells of the retina is still not clear, but researchers have shown that GARP2 accelerates retinal degeneration in mice, and have made an important step toward creating a standardized nomenclature between mice and humans for a measurement of retinal degeneration.
Tuberculosis kills 1.8 million people a year, and 10 million more are infected. Development of host-cell directed therapies that could restore cellular function during M. tuberculosis infection, such as a “release and kill” strategy, could shorten drug treatment of TB patients.
Research from UAB suggests that nearly half of children with the most common type of leukemia or their parents say they took more medications than they actually did.
The award recognizes a significant paper by Cui in Cell Death and Differentiation.
In another example of precision medicine, UAB researchers have used IPF patients own lung tissue to create models to determine the most effective medication for that patient.
Thanks to the popular TV show Blacklist, America is becoming familiar with CRISPR, a revolutionary gene-editing tool. UAB scientists and students explain how it works — and how they are using these “molecular scissors” to cut a path toward genetic cures for sickle cell and brain diseases
David Kimberlin, M.D., vice chair of Pediatrics and co-director of the Division of Pediatric Infectious Diseases, is a physician at Children’s of Alabama. He is the editor of the American Academy of Pediatrics’ Red Book, which establishes which vaccines should be given, when and to whom.
A UAB study shows that evaluation from a vision specialist should be included in return-to-learn concussion protocols.
A key Leukemia & Lymphoma Society grant will provide an opportunity for a UAB researcher to develop a new immunotherapy treatment approach for the leukemia most prevalent in Western countries.
UAB secured more than $328.5 million in federal research funding in 2015, ranking the institution No. 18 among public universities and No. 34 overall in the United States during a year in which UAB’s total research and development expenditures exceeded $516 million.

Christopher S. Brown, Ph.D., former vice president of Research for the University of North Carolina System and director and primary investigator of the NASA/North Carolina Space Grant, tapped to grow UAB’s $500 million annual research portfolio.

U.S. News & World Report ranks UAB No. 162 in its 2017 Best Global Universities ranking, up from its rank of No. 200 in 2016 and 269 spots higher than the next-highest-ranked university in Alabama.
Page 2 of 56
Back to Top